RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Allergan Inc.

A collection of news and information related to Allergan Inc. published by this site and its partners.

Top Allergan Inc. Articles

Displaying items 23-33
  • Allergan urges shareholders to reject Valeant buyout offer

    Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm. Valeant Pharmaceuticals International Inc. said last week that it will take its acquisition offer directly to...
  • Allergan urges shareholders to reject Valeant offer

    Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm. Valeant Pharmaceuticals International Inc. has offered to buy all of Allergan’s shares for a combination of...
  • Valeant again raises bid for Allergan

    Valeant again raises bid for Allergan
    For the second time in a week, Canadian drug maker Valeant Pharmaceuticals has raised its offer to acquire Botox maker Allergan Inc.  The revised offer issued Friday now lifts the proposed deal value to about $53 billion, up from Wednesday's bid of...
  • Allergan board rejects latest Valeant offer

    The board of Botox maker Allergan Inc. unanimously rejected an increased buyout offer from a Canadian pharmaceutical company as the closely watched acquisition effort showed no signs of a resolution. Valeant Pharmaceuticals International Inc. last month...
  • Valeant raises offer for Allergan for 2nd time this week

    For the second time in a week, Canadian drug maker Valeant Pharmaceuticals has raised its offer to acquire Botox maker Allergan Inc. The revised offer issued Friday lifts the proposed deal's value to about $53 billion, up from Wednesday's bid of about...
  • Ackman turns up heat on Allergan, calls for shareholder meeting

    The jockeying for control of Botox maker Allergan Inc. is getting nastier. Activist investor Bill Ackman called Monday for a special meeting at which Allergan shareholders could potentially vote out the bulk of the Irvine company's board of directors....
  • Botox-maker Allergan rejects takeover bid from Valeant

    Botox-maker Allergan Inc. said it rejected a takeover bid from Valeant Pharmaceuticals International Inc., a deal the company said undervalued its worth and posed significant risks to shareholders. Last month, the Irvine drugmaker received an...
  • Allergan rejects Valeant's takeover bid, but it's probably not over

    Botox maker Allergan Inc. rejected a $46-billion takeover offer from a Canadian rival, setting the stage for what analysts said may become a long and nasty fight for control of the Irvine company and its prized collection of eye and skin medications....
  • Valeant to increase bid for Allergan

    Valeant to increase bid for Allergan
    The stakes for Botox maker Allergan Inc. just got higher. Valeant Pharmaceutical International Inc. said it intends to raise its bid for Allergan, one day after the Irvine company defiantly rejected its initial offer as too low. In a letter to...
  • Ackman wants shareholders to push Allergan into takeover talks

    Activist investor Bill Ackman wants Allergan Inc. shareholders to vote on a resolution that would encourage the Botox maker to meet with its potential acquirer, Valeant Pharmaceuticals International Inc. In a filing Tuesday with the Securities and...
  • Shire to acquire San Diego-based Lumena in more than $260 million deal

    Drug maker Shire is buying San Diego-based Lumena Pharmaceuticals for more than $260 million, a deal that expands the company's pipeline of rare disease treatments. The Irish company, producer of Adderall XR, plans to make a cash payment at the sale's...